Cargando…
Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant
The global circulation of newly emerging variants of SARS-CoV-2 is a new threat to public health due to their increased transmissibility and immune evasion. Moreover, currently available vaccines and therapeutic antibodies were shown to be less effective against new variants, in particular, the Sout...
Autores principales: | Ryu, Dong-Kyun, Song, Rina, Kim, Minsoo, Kim, Young-Il, Kim, Cheolmin, Kim, Jong-In, Kwon, Ki-Sung, Tijsma, Aloys SL., Nuijten, Patricia M., van Baalen, Carel A., Hermanus, Tandile, Kgagudi, Prudence, Moyo-Gwete, Thandeka, Moore, Penny L., Choi, Young Ki, Lee, Soo-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180667/ https://www.ncbi.nlm.nih.gov/pubmed/34119826 http://dx.doi.org/10.1016/j.bbrc.2021.06.016 |
Ejemplares similares
-
The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2
por: Ryu, Dong-Kyun, et al.
Publicado: (2021) -
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
por: Motsoeneng, Boitumelo M., et al.
Publicado: (2023) -
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022) -
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2022) -
Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity
por: Riou, Catherine, et al.
Publicado: (2022)